ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,646.59
      0.27%
      US Tech 100
      19,739.20
      -0.54%
      Dow Jones
      40,800.41
      1.46%
      Brent Oil
      83.365
      -1.16%
      Bitcoin
      64,357.06
      -0.76%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pliant Therapeutics Inc (PLRX)

      7. Pliant Therapeutics Inc (PLRX) Financials

      Pliant Therapeutics Inc

      Pliant Therapeutics Inc (PLRX)

      NASDAQ
      13.59
      0.36
      ( 2.72% )
      Updated: 12:32:21
      Delayed by 15 minutes

      Pliant Therapeutics Inc Financial Summary

      The current PLRX market cap is 819.83M. The company's latest EPS is USD -2.6744 and P/E is -5.05.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.33M248k000
      Operating Income -42.1M-47.33M-47.69M-47.04M-52.39M
      Net Income -37.55M-41.19M-41.49M-41.11M-46.96M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 57.05M41.82M7.57M9.69M1.58M
      Operating Income -1.23M-41.65M-97.54M-127.2M-184.15M
      Net Income -6.86M-41.53M-97.26M-123.32M-161.34M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 597.88M574.89M540.46M512.15M521.61M
      Total Liabilities 35.96M41.83M37.42M38.58M84.27M
      Total Equity 561.92M533.07M503.05M473.58M437.33M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 119.06M295.53M221.22M350.61M512.15M
      Total Liabilities 9.08M12.47M22.16M37.27M38.58M
      Total Equity -76.3M283.06M199.06M313.34M473.58M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -30.28M-55.04M-91.26M-116.36M-30.27M
      Investing -174.21M-197.19M-158.93M-127.01M59.55M
      Financing 273.33M273.49M274.19M274.41M19.91M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -2.75M-37.27M-75.44M-94.63M-116.36M
      Investing -17.93M-210.87M73.7M-150.2M-127.01M
      Financing 45.54M213.21M2.53M226.85M274.41M

      Stats and Ratios

      Market Cap 819.83M
      Price to Earnings Ratio -5.05
      Price to Sales Ratio 515.65
      Price to Cash Ratio 12.89
      Price to Book Ratio 1.72
      Dividend Yield -

      Share Statistics

      Shares Outstanding 60.33M
      Average Volume (1 week) 824.54k
      Average Volume (1 Month) 628.85k
      52 Week Change -24.92%
      52 Week High 20.23
      52 Week Low 10.29
      Spread (Intraday) 0.02 (0.15%)

      Company Info

      Company Name Pliant Therapeutics Inc
      Address 850 new burton road suite 201
      dover, delaware 19904
      Website https://pliantrx.com.
      Industry pharmaceutical preparations (2834)